Selective Correlation of Interferon-gamma, Tumour Necrosis Factor-alpha and Granulocyte-macrophage Colony-stimulating Factor with Immunoglobulin G1 and Immunoglobulin G3 Subclass Antibody in Leprosy
Overview
Authors
Affiliations
Dysregulation of both B- and T-cell responses is observed in leprosy. Immunoglobulin G1 (IgG1) and IgG3 antibody subclasses are selectively elevated towards the lepromatous or disseminated form of the disease accompanied by a depression of T-cell responses. T-cell and macrophage cytokines influence antibody class switching, differentiation and proliferation of B cells. To understand the dynamic nature of the immune response in leprosy, we examined the relationship between circulating Mycobacterium leprae-specific antibodies and secreted cytokines [interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-5, IL-10, IL-6, tumour necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF)] in leprosy patients (19 lepromatous patients; 25 tuberculoid patients) and their exposed household contacts (HC=14) in response to M. leprae antigens. Paired comparison revealed a highly significant negative correlation between IFN-gamma and IgG (P=0.016), IgG1 (P<0.001) and IgG3 (P=0. 007) antibodies. No significant relationship was observed with other T-cell cytokines (IL-2, IL-5 and IL-10). These results strongly suggest that IFN-gamma may play a role in down-regulating antigen-specific IgG1 and IgG3 antibodies. Among the macrophage cytokines, TNF-alpha and GM-CSF which have not been shown to play a role in B-cell activation were positively associated with IgG1 (TNF-alpha, P=0.0005; GM-CSF, P=0.001) and IgG3 (TNF-alpha, P=0.001; GM-CSF, P=0.021) antibodies. Since macrophages have high-affinity Fc receptors for IgG1 and IgG3, it is possible that antigen uptake via these receptors may influence cytokine expression of TNF-alpha, a key modulator of disease pathogenesis in mycobacterial diseases. We are currently investigating the role of Fc receptors on activated macrophages, in expression of pro-inflammatory cytokines in mycobacterial diseases.
Disseminated intestinal basidiobolomycosis with mycotic aneurysm mimicking obstructing colon cancer.
Takrouni A, Heitham Schammut M, Al-Otaibi M, Al-Mulla M, Privitera A BMJ Case Rep. 2019; 12(1).
PMID: 30700449 PMC: 6352788. DOI: 10.1136/bcr-2018-225054.
Ma C, Wong N, Rao G, Avery D, Torpy J, Hambridge T J Allergy Clin Immunol. 2015; 136(4):993-1006.e1.
PMID: 26162572 PMC: 5042203. DOI: 10.1016/j.jaci.2015.05.036.
Inoue N, Watanabe M, Nanba T, Wada M, Akamizu T, Iwatani Y Clin Exp Immunol. 2009; 156(2):199-204.
PMID: 19250279 PMC: 2759465. DOI: 10.1111/j.1365-2249.2009.03884.x.
Thakurdas S, Hasan Z, Hussain R Clin Exp Immunol. 2004; 136(2):320-7.
PMID: 15086397 PMC: 1809011. DOI: 10.1111/j.1365-2249.2004.02459.x.
Hussain R, Shahid F, Zafar S, Dojki M, Dockrell H Immunology. 2004; 111(4):462-71.
PMID: 15056384 PMC: 1782444. DOI: 10.1111/j.0019-2805.2004.01839.x.